MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection shows promise for lowering cholesterol in indian patients
Disease control CompletedThis study tested the safety and effectiveness of inclisiran sodium, a cholesterol-lowering injection, in 65 Indian adults with high cholesterol or mixed dyslipidemia. Participants received three doses over 270 days. The goal was to see how well it lowers LDL cholesterol and if a…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug plozasiran aims to lower high fats in the blood
Disease control CompletedThis phase 2b trial tested plozasiran, an experimental drug, in 353 adults with mixed dyslipidemia (high triglycerides and cholesterol). Participants received either plozasiran or a placebo, and researchers measured changes in blood fat levels over 48 weeks. The goal is to see if…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New pill combo aims to crush high cholesterol
Disease control CompletedThis completed Phase 3 trial tested whether taking two cholesterol-lowering drugs together works better than one alone. 184 adults with high cholesterol or mixed dyslipidemia took either the combo or a single drug daily for 8 weeks. The main goal was to see how much LDL ('bad') c…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New RNA drug shows promise for cholesterol control
Disease control CompletedThis phase 2b trial tested an experimental drug called ARO-ANG3 in 204 adults with mixed dyslipidemia, a condition with high triglycerides and cholesterol. Participants received injections of the drug or a placebo over several months. The goal was to see if the drug safely lowers…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Massive Real-World study checks cholesterol Drugs' effectiveness in china
Knowledge-focused CompletedThis study looked at medical records from over 11,900 adults in China who took either inclisiran or PCSK9 mAbs to lower their high cholesterol. Researchers wanted to see how well these drugs worked in everyday medical practice, not just in controlled trials. The study found that …
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New cholesterol drug put to the test in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested a new drug called DW5124 in 55 healthy adults to see how safe it is and how the body processes it. Researchers also checked whether taking the drug with food changes its effects. The goal was to gather basic information before testing the drug in peo…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC